NEW YORK — Diagnostic equipment manufacturer Opti Medical Systems said on Thursday that its SARS-CoV-2 test kit has received Emergency Use Authorization from the US Food and Drug Administration.
The Opti SARS-CoV-2 RT-PCR kit is designed to detect viral RNA extracted from nasopharyngeal swabs, oropharyngeal swabs, bronchoalveolar lavage, and sputum samples. It provides results within three and a half hours, the company said.